Pages that link to "Q27679845"
Jump to navigation
Jump to search
The following pages link to Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2 (Q27679845):
Displaying 50 items.
- Erb-b2 receptor tyrosine kinase 2 (Q415271) (← links)
- Heat shock protein 90 alpha family class A member 1 (Q21108142) (← links)
- Heat shock protein 90 beta family member 1 (Q21131370) (← links)
- Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future (Q26748800) (← links)
- Endoplasmic reticulum chaperones and oxidoreductases: critical regulators of tumor cell survival and immunorecognition (Q26823628) (← links)
- An essential nonredundant role for mycobacterial DnaK in native protein folding (Q27314706) (← links)
- Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94 (Q28075479) (← links)
- Mechanistic Asymmetry in Hsp90 Dimers (Q28080783) (← links)
- Selective targeting of the stress chaperome as a therapeutic strategy (Q28248791) (← links)
- Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants (Q28550576) (← links)
- Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β (Q28829208) (← links)
- Hsp90 regulation of fibroblast activation in pulmonary fibrosis (Q30838920) (← links)
- Differential requirement of GRP94 and GRP78 in mammary gland development. (Q33788940) (← links)
- Protein chaperones: a composition of matter review (2008 - 2013). (Q34013266) (← links)
- Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice (Q34529312) (← links)
- Blockage of conformational changes of heat shock protein gp96 on cell membrane by a α-helix peptide inhibits HER2 dimerization and signaling in breast cancer (Q35511662) (← links)
- Sialidases as regulators of bioengineered cellular surfaces. (Q35678457) (← links)
- High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma (Q35789280) (← links)
- Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94 (Q35899122) (← links)
- The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis (Q36059002) (← links)
- Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease (Q36655158) (← links)
- FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies (Q36688951) (← links)
- A Human Variant of Glucose-Regulated Protein 94 That Inefficiently Supports IGF Production (Q36911625) (← links)
- Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold (Q37164519) (← links)
- Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells (Q37167969) (← links)
- Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells. (Q37687316) (← links)
- Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential (Q38198491) (← links)
- The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer (Q38210012) (← links)
- Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease (Q38234720) (← links)
- Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside? (Q38502737) (← links)
- Intracellular antigens as targets for antibody based immunotherapy of malignant diseases (Q38644355) (← links)
- Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors (Q38655003) (← links)
- Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series (Q38735183) (← links)
- The epichaperome is an integrated chaperome network that facilitates tumour survival (Q38739896) (← links)
- Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects (Q38750417) (← links)
- Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma (Q38807896) (← links)
- Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma (Q38825761) (← links)
- Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR (Q38891038) (← links)
- Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer (Q38924681) (← links)
- Development of radamide analogs as Grp94 inhibitors (Q38975022) (← links)
- Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma (Q39090150) (← links)
- Alternative approaches to Hsp90 modulation for the treatment of cancer (Q39103704) (← links)
- Structural and Functional Analysis of GRP94 in the Closed State Reveals an Essential Role for the Pre-N Domain and a Potential Client-Binding Site. (Q41705197) (← links)
- Specific Binding of Tetratricopeptide Repeat Proteins to Heat Shock Protein 70 (Hsp70) and Heat Shock Protein 90 (Hsp90) Is Regulated by Affinity and Phosphorylation (Q41884789) (← links)
- 5'-N-ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor (Q44586980) (← links)
- Targeting protein quality control pathways in breast cancer (Q46087491) (← links)
- Gene expression regulation by heat-shock proteins: the cardinal roles of HSF1 and Hsp90. (Q47259561) (← links)
- Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal Inhibitors. (Q47616767) (← links)
- Resorcinol-Based Grp94-Selective Inhibitors (Q47619180) (← links)
- Proteomic interrogation of HSP90 and insights for medical research (Q47678542) (← links)